Supplementary Protocol S1 from Durvalumab plus Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: An Open-label, Nonrandomized, Phase II Clinical Trial

Authors :: Trisha M. Wise-Draper
Nusrat Harun
Roman Jandarov
Nicky Kurtzweil
Sarah Palackdharry
Ilaina Monroe
Maria Lehn
Vinita Takiar
Muhammed Kashif Riaz
McKenzie Crist
Shuchi Gulati
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Study protocol

Full Text Access

Tools